BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24075582)

  • 1. Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Rouco I; Hurtado P; Castaño L; Zarranz JJ
    Neurologia; 2015 May; 30(4):247-9. PubMed ID: 24075582
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Virgilio R; Corti S; Agazzi P; Santoro D; Lanfranconi S; Candelise L; Bresolin N; Comi GP; Bersano A
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):95-6. PubMed ID: 19091718
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.
    di Biase L; Assenza G; Iorio R; Melgari JM; Salomone G; Marano M; Muda AO; Di Lazzaro V
    Parkinsonism Relat Disord; 2016 Sep; 30():78-80. PubMed ID: 27236207
    [No Abstract]   [Full Text] [Related]  

  • 4. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Planche V; Marques A; Ulla M; Ruivard M; Durif F
    Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.
    Ishida K; Mitoma H; Wada Y; Oka T; Shibahara J; Saito Y; Murayama S; Mizusawa H
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):190-2. PubMed ID: 17119008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Abele M; Weller M; Mescheriakov S; Bürk K; Dichgans J; Klockgether T
    Neurology; 1999 Mar; 52(4):857-9. PubMed ID: 10078741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
    Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
    Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.
    Takenoshita H; Shizuka-Ikeda M; Mitoma H; Song S; Harigaya Y; Igeta Y; Yaguchi M; Ishida K; Shoji M; Tanaka M; Mizusawa H; Okamoto K
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):386-9. PubMed ID: 11181864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly progressing cerebellar ataxia associated with anti-GAD antibodies.
    Quintas S; Ruiz RL; Zapata-Wainberg G; Vivancos J
    Neurologia (Engl Ed); 2018 May; 33(4):273-275. PubMed ID: 27091680
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.
    Ariño H; Gresa-Arribas N; Blanco Y; Martínez-Hernández E; Sabater L; Petit-Pedrol M; Rouco I; Bataller L; Dalmau JO; Saiz A; Graus F
    JAMA Neurol; 2014 Aug; 71(8):1009-16. PubMed ID: 24934144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
    Mirabelli-Badenier M; Morana G; Pinto F; Uccelli A; Veneselli E; Battaglia FM; Biancheri R; Baglietto MG; Vincent A; Mancardi MM
    Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
    Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
    Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report.
    Villa SM; Rufa A; Malandrini A; Cerase A; Rosini F; Arrigucci U; Federico A
    Neurol Sci; 2019 Jun; 40(6):1303-1306. PubMed ID: 30635801
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase.
    Simon NG; Vucic S; Joffe R; Kiernan MC
    J Neurol; 2014 Jan; 261(1):238-9. PubMed ID: 24292643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.